Finnish-Kenyan AIDS drug aims for global market

Business November 10, 2011

A Kenya-based pharmaceutical company in Finnfund’s investment portfolio has gained WHO approval for an HIV drug which now opens access to the giant UN and Global Fund market.

If you are new to Development Today and would like to continue reading this article, send us a mail at subscribers@devtoday.no, including your name, title, organisation, and email contact, and you will receive a free Guest Pass, along with weekly updates.